2 results about "Chronic glomerulonephritis" patented technology

The invention discloses a medicinal moxa composition for preventing and treating codiseases of beriberi and chronic glomerulonephritis. The medicinal moxa composition is prepared from radix aconiti carmichaeli, cortex cinnamomi, cornu cervi pantotrichum, rhizoma alismatis, radix achyranthis bidentatae and moxa. The medicinal moxa composition disclosed by the invention has remarkable external antibacterial and warming effects, consists of five yang warming medicines and one warming medicine, releases volatile components through combustion, and stimulates acupuncture points in combination with heating power, so that the dual effects of treating beriberi and chronic glomerulonephritis are achieved. The radix aconiti carmichaeli, cinnamon, cornu cervi pantotrichum, rhizoma alismatis, radix achyranthis bidentatae and wormwood in the formula form a unique synergistic effect mechanism in the external use process, so that the medicinal components directly reach the focus through skin penetration, and meanwhile, the qi and blood of the whole body are regulated. Through infrared radiation, volatile antibacterial components and a warming effect generated by combustion of the medicinal moxa, the dual treatment effects of external warming and dredging and internal qi and blood regulation are achieved, and a new thought is provided for treatment of foot fungal infection and kidney meridian dysfunction.

To provide an ATP production promoter useful for preventing or treating diseases associated with decreased ATP production, particularly renal impairment. [Solution] The present invention comprises an ATP production promoter containing a component having URAT1 inhibitory activity. Preferably, the component having URAT1 inhibitory activity is at least one selected from the group consisting of benzbromarone, probenecid, dotinurad, recinurad, and berinurad. The present invention is expected to be useful as a preventive and therapeutic agent for diseases of decreased ATP production, and is particularly useful as a therapeutic and / or preventive agent for nephrotic syndrome, chronic glomerulonephritis, chronic tubulointerstitial nephritis, chronic pyelonephritis, amyloid kidney, familial juvenile hyperuricemia nephropathy, autosomal dominant tubulointerstitial kidney disease, nephronoplasia, renovascular hypertension, renal vein thrombosis, renal arteriovenous fistula, renal tubular acidosis, Gitelman syndrome, Bartter syndrome, Fanconi syndrome, Lowe syndrome, Alport syndrome, kidney and ureteral stones, and chronic renal failure.